Clinical Trial Update: Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating an influenza A/H3N2 vaccine in patients with systemic lupus erythematosus and Sjogren's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjogren Syndrome
• Systemic Lupus Erythematosus

Drugs mentioned

• influenza A/H3N2 vaccine

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Systemic Lupus, Sjogren's Syndrome | Phase 4 | Status: COMPLETED